![Adrian Senderowicz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Senderowicz
Direktör/Styrelseledamot på
PUMA BIOTECHNOLOGY, INC.
Förmögenhet: 193 590 $ per 2026-05-31
Profil
Adrian M.
Senderowicz is currently an Independent Director at Puma Biotechnology, Inc. since 2015 and a Director at Step Pharma SAS since 2021.
Former roles include Senior Medical Director-Oncology Division at AstraZeneca PLC from 2008 to 2012; Chief Medical Officer & VP-Medical Development at Tokai Pharmaceuticals, Inc. from 2012 to 2013; Vice President-Global Regulatory Oncology at Sanofi from 2013 to 2014; Chief Medical Officer & SVP-Regulatory Affairs at Ignyta, Inc. from 2014 to 2015; Chief Medical Officer & Senior Vice President at Cerulean Pharma, Inc. from 2015 to 2017; Chief Medical Officer & Senior Vice President at Daré Bioscience, Inc. from 2015 to 2017; Chief Medical Officer & Senior Vice President at Constellation Pharmaceuticals, Inc. from 2017 to 2020; Non-Executive Director at Oncoinvent ASA (Old); Head-Prostate Cancer Clinic at National Institutes of Health; and Clinical Team Leader-Oncology Division at US Food & Drug Administration.
Education includes a doctorate from Universidad de Buenos Aires.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC. 0,05 % | 2026-04-13 | 27 000 ( 0,05 % ) | 193 590 $ | 2026-05-31 |
Aktiva positioner av Adrian Senderowicz
| Företag | Position | Start |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Direktör/Styrelseledamot | 2015-08-11 |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Direktör/Styrelseledamot | 2021-10-06 |
Tidigare kända positioner av Adrian Senderowicz
| Företag | Position | Slut |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2020-06-22 |
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Teknisk/Vetenskaplig/F&U Direktör | 2017-06-15 |
| DARÉ BIOSCIENCE, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2017-06-01 |
| IGNYTA INC | Teknisk/Vetenskaplig/F&U Direktör | 2015-04-01 |
| SANOFI | Företagsledare/Principal | 2014-08-01 |
Utbildning av Adrian Senderowicz
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
65
Första gradens relationer
13
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 13 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Health Technology |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Health Technology |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
Daré Bioscience, Inc.
 Daré Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
